Literature DB >> 27992402

The ubiquitin E3 ligase TRIM31 promotes aggregation and activation of the signaling adaptor MAVS through Lys63-linked polyubiquitination.

Bingyu Liu1, Meng Zhang2, Honglei Chu1, Honghai Zhang1, Haifeng Wu1, Guanhua Song1, Peng Wang1, Kai Zhao1, Jinxiu Hou1, Xueer Wang1, Lei Zhang1, Chengjiang Gao1.   

Abstract

The signaling adaptor MAVS forms prion-like aggregates to activate an innate antiviral immune response after viral infection. However, the molecular mechanisms that regulate MAVS aggregation are poorly understood. Here we identified TRIM31, an E3 ubiquitin ligase of the TRIM family of proteins, as a regulator of MAVS aggregation. TRIM31 was recruited to mitochondria after viral infection and specifically regulated antiviral signaling mediated by RLR pattern-recognition receptors. TRIM31-deficient mice were more susceptible to infection with RNA virus than were wild-type mice. TRIM31 interacted with MAVS and catalyzed the Lys63 (K63)-linked polyubiquitination of Lys10, Lys311 and Lys461 on MAVS. This modification promoted the formation of prion-like aggregates of MAVS after viral infection. Our findings reveal new insights in the molecular regulation of MAVS aggregation and the cellular antiviral response through TRIM31-mediated K63-linked polyubiquitination of MAVS.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27992402     DOI: 10.1038/ni.3641

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  36 in total

Review 1.  The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors.

Authors:  Taro Kawai; Shizuo Akira
Journal:  Nat Immunol       Date:  2010-04-20       Impact factor: 25.606

2.  VISA is an adapter protein required for virus-triggered IFN-beta signaling.

Authors:  Liang-Guo Xu; Yan-Yi Wang; Ke-Jun Han; Lian-Yun Li; Zhonghe Zhai; Hong-Bing Shu
Journal:  Mol Cell       Date:  2005-09-16       Impact factor: 17.970

Review 3.  Toll-like receptor and RIG-I-like receptor signaling.

Authors:  Taro Kawai; Shizuo Akira
Journal:  Ann N Y Acad Sci       Date:  2008-11       Impact factor: 5.691

Review 4.  Structural mechanism of RNA recognition by the RIG-I-like receptors.

Authors:  Mitsutoshi Yoneyama; Takashi Fujita
Journal:  Immunity       Date:  2008-08-15       Impact factor: 31.745

Review 5.  Innate immune sensing and signaling of cytosolic nucleic acids.

Authors:  Jiaxi Wu; Zhijian J Chen
Journal:  Annu Rev Immunol       Date:  2014       Impact factor: 28.527

6.  Reconstitution of the RIG-I pathway reveals a signaling role of unanchored polyubiquitin chains in innate immunity.

Authors:  Wenwen Zeng; Lijun Sun; Xiaomo Jiang; Xiang Chen; Fajian Hou; Anirban Adhikari; Ming Xu; Zhijian J Chen
Journal:  Cell       Date:  2010-04-16       Impact factor: 41.582

7.  Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway.

Authors:  Lijun Sun; Jiaxi Wu; Fenghe Du; Xiang Chen; Zhijian J Chen
Journal:  Science       Date:  2012-12-20       Impact factor: 47.728

8.  Crystal structure and mechanism of activation of TANK-binding kinase 1.

Authors:  Amede Larabi; Juliette M Devos; Sze-Ling Ng; Max H Nanao; Adam Round; Tom Maniatis; Daniel Panne
Journal:  Cell Rep       Date:  2013-02-28       Impact factor: 9.423

9.  NLRX1 is a regulator of mitochondrial antiviral immunity.

Authors:  Chris B Moore; Daniel T Bergstralh; Joseph A Duncan; Yu Lei; Thomas E Morrison; Albert G Zimmermann; Mary A Accavitti-Loper; Victoria J Madden; Lijun Sun; Zhengmao Ye; John D Lich; Mark T Heise; Zhijian Chen; Jenny P-Y Ting
Journal:  Nature       Date:  2008-01-16       Impact factor: 49.962

10.  Smurf2 negatively modulates RIG-I-dependent antiviral response by targeting VISA/MAVS for ubiquitination and degradation.

Authors:  Yu Pan; Rui Li; Jun-Ling Meng; He-Ting Mao; Yu Zhang; Jun Zhang
Journal:  J Immunol       Date:  2014-04-11       Impact factor: 5.422

View more
  109 in total

1.  The Andes Orthohantavirus NSs Protein Antagonizes the Type I Interferon Response by Inhibiting MAVS Signaling.

Authors:  Jorge Vera-Otarola; Loretto Solis; Fernando Lowy; Valeria Olguín; Jenniffer Angulo; Karla Pino; Nicole D Tischler; Carola Otth; Paula Padula; Marcelo López-Lastra
Journal:  J Virol       Date:  2020-06-16       Impact factor: 5.103

Review 2.  Structural Variability in the RLR-MAVS Pathway and Sensitive Detection of Viral RNAs.

Authors:  Qiu-Xing Jiang
Journal:  Med Chem       Date:  2019       Impact factor: 2.745

Review 3.  TRIM Proteins and Their Roles in Antiviral Host Defenses.

Authors:  Michiel van Gent; Konstantin M J Sparrer; Michaela U Gack
Journal:  Annu Rev Virol       Date:  2018-06-27       Impact factor: 10.431

Review 4.  TRIMs: selective recruitment at different steps of the NF-κB pathway-determinant of activation or resolution of inflammation.

Authors:  Milton Roy; Rajesh Singh
Journal:  Cell Mol Life Sci       Date:  2021-07-20       Impact factor: 9.261

Review 5.  Ubiquitin-Modifying Enzymes and Regulation of the Inflammasome.

Authors:  Michael G Kattah; Barbara A Malynn; Averil Ma
Journal:  J Mol Biol       Date:  2017-10-13       Impact factor: 5.469

6.  Reply to Rubinstein: Is Lgr4 essential for VSV- and VSV-G-pseudotyped lentiviral vector entry to cells?

Authors:  Na Zhang; Bing Du
Journal:  J Biol Chem       Date:  2018-01-05       Impact factor: 5.157

7.  HECTD3 mediates TRAF3 polyubiquitination and type I interferon induction during bacterial infection.

Authors:  Fubing Li; Yang Li; Huichun Liang; Tao Xu; Yanjie Kong; Maobo Huang; Ji Xiao; Xi Chen; Houjun Xia; Yingying Wu; Zhongmei Zhou; Xiaomin Guo; Chunmiao Hu; Chuanyu Yang; Xu Cheng; Ceshi Chen; Xiaopeng Qi
Journal:  J Clin Invest       Date:  2018-07-30       Impact factor: 14.808

8.  Tripartite motif proteins: an emerging antiviral protein family.

Authors:  Girish Patil; Shitao Li
Journal:  Future Virol       Date:  2019-01-21       Impact factor: 1.831

9.  TRAF3IP3 mediates the recruitment of TRAF3 to MAVS for antiviral innate immunity.

Authors:  Wenting Zhu; Jiaxin Li; Rui Zhang; Yixiang Cai; Changwan Wang; Shishi Qi; She Chen; Xiaozhen Liang; Nan Qi; Fajian Hou
Journal:  EMBO J       Date:  2019-08-07       Impact factor: 11.598

10.  TRIM29 Negatively Regulates the Type I IFN Production in Response to RNA Virus.

Authors:  Junji Xing; Ao Zhang; Laurie J Minze; Xian Chang Li; Zhiqiang Zhang
Journal:  J Immunol       Date:  2018-05-16       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.